InvestorsHub Logo
Followers 47
Posts 3929
Boards Moderated 0
Alias Born 03/04/2012

Re: frenchbroad post# 398470

Sunday, 07/16/2023 5:59:19 PM

Sunday, July 16, 2023 5:59:19 PM

Post# of 402749
The "correct offer" sometimes comes when least expected. Good to see patent protection.

... the United States Patent and Trade Office (USPTO), on June 6, 2023, granted a patent, “Host Defense Protein (HDP) Mimetics for Prophylaxis and/or Treatment of Inflammatory Diseases of the Gastrointestinal Tract,” and also recently issued a Notice of Allowance for the patent application, “Arylamide Compounds For Treatment Of Viral Infections.”

These allowed patents, which encompass Brilacidin protections through 2036 and 2041, respectively, further strengthen Brilacidin intellectual property rights previously granted in the U.S. and other regions. Brilacidin is a Host Defense Protein-mimetic drug candidate with broad-spectrum immunomodulatory and antimicrobial properties.



https://www.ipharminc.com/press-release/2023/6/21/innovation-pharmaceuticals-provides-update-on-us-patent-applications-covering-use-of-brilacidin-in-inflammatory-bowel-diseases-coronaviruses-and-fungal-diseases
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News